Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

548 results about "Whole cell" patented technology

Biosynthesis system for high yield of 1, 6-hexamethylenediamine and application of biosynthesis system

The invention discloses a biosynthesis system for high-yield 1, 6-hexamethylenediamine and application of the biosynthesis system, and belongs to the technical field of biology. According to the method, key genes which are excavated and optimized in a 1, 6-hexamethylenediamine biosynthetic pathway are co-expressed in a single cell module or a multi-cell module, and different enzyme elements expressed by the cell module are subjected to enzyme cascade reaction, so that 1, 6-hexamethylenediamine can be efficiently synthesized by taking caprolactam or 6-aminocaproic acid as a substrate; furthermore, after the carboxylic acid reductase MaCAR is mutated, the catalytic activity of the carboxylic acid reductase MaCAR can be remarkably improved, and the yield of the 1, 6-hexamethylenediamine is further improved; in addition, the biosynthesis system disclosed by the invention directly takes the cell module as a whole-cell catalyst, and an enzyme purification step is avoided, so that the biosynthesis system has the advantage of low cost.
Owner:HUBEI UNIV

Method for efficiently synthesizing epiinositol by using heat-resistant myo-inositol dehydrogenase mutant cascade system

PendingCN119799803ABacteriaMicroorganism based processesInositol synthesisChiro-inositol
The invention discloses a method for efficiently synthesizing epiinositol by using a heat-resistant myo-inositol dehydrogenase mutant cascade system, and belongs to the field of biocatalysis engineering. Whole cells for expressing a scyllo-inositol dehydrogenase mutant and a heat-resistant scyllo-inositol dehydrogenase mutant are utilized to catalyze the scyllo-inositol to synthesize the epiinositol in a two-step cascade manner, and different from reported scyllo-inositol and D-chiral inositol synthesis methods, in the process of synthesizing the epiinositol by taking the scyllo-inositol as a substrate, the C4 position of the scyllo-inositol is dehydrogenated firstly, then the C4 position of the scyllo-inositol is dehydrogenated, and the C4 position of the D-chiral inositol According to the present invention, the structure of the substrate and the structure of the product are symmetric, and the enzyme is difficult to specifically recognize during the catalysis process, such that the synthesis of the different chiral compounds of the inositol is the important problem in the biological catalysis field. The invention provides a brand-new way for biocatalytically synthesizing the epiinositol, the yield of the epiinositol is increased to 1.89 g / L through enzyme modification, the conversion rate is 52.6%, and the yield and the conversion rate are the highest level reported publicly at present.
Owner:JIANGNAN UNIV

Arginine decarboxylase diaA enzyme mutant and application thereof in preparation of butanediamine

ActiveCN121737107ABacteriaHydrolasesDimerPentamer
The invention discloses an arginine decarboxylase diaA enzyme mutant and application thereof in preparation of butanediamine, and belongs to the field of bioengineering. According to the invention, rational charge overturning transformation is simultaneously carried out on a pentamer meridian oligomeric interface and a dimer latitudinal oligomeric interface, so that stable assembly and efficient catalysis of the decamer under the condition of neutral to alkaline pH (7.0-9.0) are realized. Wherein positive charges are introduced into a meridian interface to weaken electrostatic repulsion, and negative charges are introduced into a latitudinal interface to enhance dimer compactness and substrate transfer efficiency. The specific enzyme activity of the representative double mutant AdiAD110K / H736E at pH 8.0 is about 35 times that of a wild type, and the representative double mutant AdiAD110K / H736E keeps a complete decamer state in a pH range of 7.0-9.0. The yield of butanediamine is up to 145.9 g / L under the whole-cell catalysis of the mutant.
Owner:JIANGNAN UNIV

Composition for predicting and evaluating curative effect of cancer treatment and detection method

The invention relates to a composition for predicting and evaluating the curative effect of cancer treatment and a detection method. The curative effect of a treatment method is predicted or evaluated by detecting the content of specific subtype immune cells in peripheral blood, peripheral immune organs or tumor tissues of a patient treated by the treatment method to be detected. The method specifically comprises the following steps: firstly, separating to obtain immune cells in peripheral blood, peripheral immune organs or tumor tissues; then co-incubating the obtained immune cells with the nanoparticles and / or micron particles loaded with the tumor whole-cell antigen for a period of time, and detecting the content of T cell subtypes or / and the content of B cell subtypes containing specific cell markers in the obtained immune cells by using methods such as flow cytometry, chemiluminescence or a paramagnetic particle method. Whether a certain cancer treatment method is effective or not can be judged according to the content of the T cell subtype or / and the B cell subtype containing the specific cell marker.
Owner:SUZHOU ERSHENG BIOPHARMACEUTICAL CO LTD

Photovoltaic module

The invention relates to a photovoltaic module, the photovoltaic module comprises three battery string groups which are connected in series, each battery string group comprises four battery strings which are connected in parallel, each battery string comprises a plurality of fragmented battery pieces, and each fragmented battery piece is a quarter piece formed by cutting a whole battery piece; the three battery string groups which are connected in series are distributed along a first direction, and a plurality of fragmented battery pieces in the battery strings are distributed along a second direction; the heads and the tails of the battery strings are connected with the bus bars, the bus bars comprise first bus bars located at the two ends of the photovoltaic module in the second direction and second bus bars located in the middle of the photovoltaic module in the second direction, and the first bus bars are located on the back face of the photovoltaic module. According to the photovoltaic module, on one hand, one half of the fragmented battery piece in the battery string is replaced by one fourth of the fragmented battery piece, and on the other hand, the photoelectric conversion efficiency of the photovoltaic module is relatively high by enabling the first bus bar to be located on the back surface of the photovoltaic module.
Owner:JINKO SOLAR CO LTD +1

S-adenosylmethionine synthetase mutants and use thereof

PCT designated stageWO2026046146A1BacteriaTransferasesMicroorganismS-Adenosylmethionine Synthetase
Provided are S-adenosylmethionine synthetase mutants and the use thereof, belonging to the technical field of biological enzyme engineering. Site-directed combinatorial mutations are performed on positions 189, 200, 234, 266 and 371 of S-adenosylmethionine synthetase MAT to obtain a series of mutants with improved enzyme activity, wherein the specific enzyme activity of I189V / V266H and V266H / N371R is increased by more than 10 times relative to the parent. The yields of S-adenosylmethionine synthesized by whole cells of recombinant bacteria expressing mutants I189V / V266H / N371R, V266H / Q234N / N371R and I189V / V266H / Q234N / N371R all reach 1550 mg / L or more. The provided enzyme mutants have broad application prospects in the production of S-adenosylmethionine and the construction of genetically engineered microorganisms for S-adenosylmethionine.
Owner:JIANGNAN UNIV

Lysine decarboxylase mutant and application thereof in synthesis of pentamethylene diamine

The invention discloses a high-efficiency lysine decarboxylase mutant and an application of the high-efficiency lysine decarboxylase mutant in synthesis of pentamethylene diamine. A series of mutants including a single mutant (such as N218G, T222V, C244P and the like), a double mutant and a three mutant are obtained by carrying out multi-site mutation on wild type lysine decarboxylase (SEQ ID NO.2) from Klebsiella grimontii. The catalytic efficiency of the mutant is remarkably improved, and the activity of the mutant is improved by 5.0-10.2 times compared with that of a wild type enzyme. According to the method disclosed by the invention, the substrate conversion rate of 99% or above can be realized within 2 hours through an optimized process of constructing an expression vector and a genetically engineered bacterium, inducing expression of lysine decarboxylase and synthesizing 1, 5-pentanediamine by utilizing a whole-cell catalysis technology. Compared with a traditional chemical method and a natural enzyme method, the method disclosed by the invention has the advantages of simplified process, high catalytic efficiency, low production cost and the like, and is suitable for producing bio-based 1, 5-pentamethylene diamine and nylon 56 salt.
Owner:MEIBANG MEIHE BIOTECHNOLOGY CO LTD

Magnetic hydrogel coated bacterial biosensor platform and application

The invention discloses a magnetic hydrogel coated bacterial biosensor platform and application, and belongs to the field of synthetic biology and clinical diagnosis. The hydrogel delivery and recovery system comprises a hydrogel-coated whole-cell biosensor and magnetic particles, the hydrogel is constructed by sodium alginate and calcium chloride, and the biosensor is a bacterium for sensing heme. More specifically, engineering bacteria YES601 and magnetic Fe3O4 particles are packaged by sodium alginate hydrogel to form magnetic hydrogel microspheres, the magnetic hydrogel microspheres are delivered to intestinal tracts as a biosensor and can sense heme to emit light, and then complete microspheres are efficiently recovered from excrement in a magnetic adsorption mode for detection. The intestinal bleeding detection efficiency and safety of the whole-cell biosensor are improved. According to the overall design optimization strategy of the hydrogel delivery and recovery system, the diagnosis efficiency and the practical application value can be improved.
Owner:EAST CHINA UNIV OF SCI & TECH

4-hydroxyphenylacetic acid-3-hydroxylase mutant with improved activity and application thereof

The invention discloses a 4-hydroxyphenylacetic acid-3-hydroxylase mutant with improved activity and application thereof, the 4-hydroxyphenylacetic acid-3-hydroxylase mutant is obtained by mutating wild type 4HPA3H enzyme from Escherichia coli, the amino acid sequence of the wild type 4HPA3H enzyme is as shown in SEQ ID No.1, and the amino acid sequence is specifically mutated into any one of the following: (1) M205F; and (2) T398S. According to the present invention, the whole-cell catalysis activity of the 4-hydroxyphenylacetic acid-3-hydroxylase mutant, the M205F mutant and the T398S mutant on the p-hydroxyphenyllactic acid is improved by 1.70 times and 1.24 times compared with the WT;
Owner:NINGBO INST OF TECH ZHEJIANG UNIV ZHEJIANG

Escherichia coli for producing lactose-N-tetrasaccharide and double-bacterium coupling fermentation method based on escherichia coli

The invention discloses escherichia coli for producing lactose-N-tetrasaccharide and a double-bacterium coupling fermentation method based on the escherichia coli. The method comprises the following steps: firstly, constructing an LNT biosynthetic pathway in escherichia coli; the method comprises the following steps: firstly, constructing a double-plasmid system, then carrying out combinatorial optimization on the double-plasmid system, constructing four engineering bacteria, screening out an EP3 strain (containing galT1-SP and galE-Cv beta 3GalT expression cassette), and carrying out coupled fermentation on the screened EP3 strain and yeast to produce LNT with the optimal capacity, so that 25.2 g / L of LNT can be produced, and the molar conversion rate (mol / mol LNT II) is 71.22%. A production system is optimized, the influence of UTP and UMP as cofactors on LNT synthesis is compared, 29.4 g / L of LNT can be generated when only 20 mM of UMP is added as a cofactor, and the molar conversion rate (mol / mol LNT II) is 83.09%. And finally, performing fed-batch culture on the EP3 strain, and performing whole-cell catalysis to generate 39.6 g of LNT. The invention provides a new strategy for efficiently and cheaply producing the LNT.
Owner:JIANGNAN UNIV

Pinpointing single molecule positions with in situ point spread function retrieval for three dimensional nanoscopy of whole cells and tissues

ActiveUS12210167B2Image enhancementImage analysisPupil functionEntire cell
A method of in situ point spread function (PSF) retrieval is disclosed which includes encoding 3D location of molecules into PSFs, receiving molecule-generated images containing PSFs, segmenting the images into sub-PSF, initializing template PSFs from a pupil function, determining a statistical measure of a predetermined function between the sub- and template PSFs, associating each of the sub-PSFs with a template PSF, aligning and averaging the sub-PSF, applying a phase retrieval algorithm to the averaged sub-PSFs to update the pupil function, regenerating the template PSFs, repeating until a difference between a new and a prior generation pupil function is below a predetermined threshold, generating in situ PSFs from the last pupil function, and applying a maximum likelihood estimation algorithm based on the in situ PSFs and the sub-PSF to thereby generate lateral and axial locations of molecules.
Owner:PURDUE RES FOUND

Heat-resistant fatty acid photo-decarboxylase mutant based on continuous site combination mutation and application of heat-resistant fatty acid photo-decarboxylase mutant

ActiveCN119040308AEffect of heat resistanceImprove heat resistanceBacteriaMicroorganism based processesTridecaneOrganic solvent
The invention discloses a heat-resistant fatty acid light decarboxylase mutant based on continuous site combination mutation and application thereof, and belongs to the technical field of enzyme engineering. A continuous site combination mutant library is constructed aiming at the chlorella-derived fatty acid light decarboxylase CvFAP, an 8-site combination mutant M8 is screened, the optimal reaction temperature of the combination mutant M8 is 45 DEG C and is increased by 15 DEG C compared with that of the CvFAP, 50% of activity of the combination mutant M8 is reserved under the condition of 55 DEG C, and the CvFAP almost has no activity at the temperature. The method breaks through the limitation that the optimum catalytic temperature of the conventional CvFAP is 30 DEG C and the substrate fatty acid depends on the hydrotropy of organic solvents such as dimethyl sulfoxide and the like. Under the conditions that the temperature is 55 DEG C higher than the melting point of myristic acid and no organic solvent is used for assisting dissolving, the myristic acid is efficiently catalyzed by whole cells containing the mutant M8 to generate tridecane. The invention provides a prospect for the application of the fatty acid photo-decarboxylase under the conditions of high temperature and no need of an organic cosolvent.
Owner:DALIAN UNIV OF TECH

ScATAC-seq data-based ecDNA identification method

The invention discloses an ecDNA (ectodeoxyribonucleic acid) identification method based on scATAC-seq (scATAC-Seq) data. The ecDNA recognition method provided by the invention can be used for accurately detecting copy number amplification, breakpoint quantity and ecDNA feature quantity on the whole cell level. According to the method provided by the invention, the specific carried annular oncogene in the tumor can be identified, the distribution characteristics of the annular oncogene in the genome can be analyzed, and the overall composition of all annular DNAs in a single cell and the specific composition of the single annular DNA can be disclosed. In addition, according to the method, the existence of the circular DNA can be verified through a dyeing experiment, and the reliability of a detection result is ensured.
Owner:KUNMING MEDICAL UNIVERSITY

Genetically engineered bacterium and method for producing icaritin through whole-cell catalysis

PendingCN119530121ABacteriaTransferasesEscherichia coliCholine kinase
The invention relates to the technical field of bioengineering, and discloses a genetically engineered bacterium and a method for producing icaritin through whole-cell catalysis. By constructing double plasmids, choline kinase, isopentenyl phosphokinase, flavonoid 3-hydroxylase, flavonol synthase, isopentenyl transferase and oxymethyltransferase are simultaneously overexpressed in escherichia coli, so that a genetically engineered bacterium is constructed, and the engineering bacterium is used as a whole-cell catalyst to prepare a whole-cell engineering bacterium. The naringenin and the 3-methyl-2-butene-1-ol are used as substrates to be converted into the icaritin in a whole-cell catalysis mode, only one-step reaction is needed, the method is simple, rapid and high in efficiency, other chemical substances do not need to be additionally added in the conversion process, the cost is reduced, pollution to the environment is relieved, and the method is suitable for industrial production. And the biological production from low-price naringenin to high-added-value icaritin is realized.
Owner:HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD

Mutant with improved S-adenosylmethionine synthetase catalytic activity and application thereof

ActiveCN120758471ABacteriaTransferasesMicroorganismS-Adenosylmethionine Synthetase
The invention discloses a mutant with improved catalytic activity of S-adenosylmethionine synthetase and application of the mutant, and belongs to the technical field of biological enzyme engineering. According to the present invention, the site 189, the site 234, the site 266 and the site 371 of the S-adenosylmethionine synthetase MAT are subjected to site-specific combinatorial mutation to obtain a series of mutants with improved enzyme activity, the I189V / V266H improvement is the most obvious, and the specific enzyme activity is 3.5833 + / -0.1373 U.mg <-1 >, which is improved by 1353.08% compared to the parent WT; and for a whole-cell catalysis system, the yield of S-ademetionine synthesized by the mutant I189V / V266H / Q234N / N371R reaches 1751.01 mg / L, and the increase is most obvious. The enzyme mutant provided by the invention has a wide application prospect in the production of S-adenosylmethionine and the construction of genetic engineering microorganisms of S-adenosylmethionine.
Owner:JIANGNAN UNIV

Single cell Hi-C atlas interpolation method and device

PendingCN119694388ABiostatisticsProteomicsAlgorithmBiocomputer
The invention relates to the technical field of biological computing, in particular to a single-cell Hi-C atlas interpolation method and device, and the method comprises the steps: obtaining single-cell sequencing library data and a reference genome, determining the position of the sequencing data in the genome, and carrying out the statistics of the interaction frequency to obtain a Hi-C contact matrix; performing interpolation on the Hi-C contact matrix of any chromatin of the single cell according to similarity of adjacent nodes to obtain an adjacent node interpolation map of the single chromatin of the single cell; calculating an interpolation map of each chromatin of each cell, performing representation learning by taking the interpolation map as an adjacent matrix, splicing vectors to obtain a cell pre-embedded vector, and performing dimensionality reduction to obtain a whole cell embedded vector matrix; a cellular level similarity matrix is calculated by using a single cell embedded vector matrix and converted into a Markov probability transfer matrix, and the Markov probability transfer matrix is used for correcting an adjacent node interpolation map to obtain a Hi-C interpolation map, so that the interpolation accuracy is improved.
Owner:XI'AN UNIVERSITY OF ARCHITECTURE AND TECHNOLOGY

Alpha-glucosidase mutant and application thereof in synthesis of alpha-arbutin

The invention provides an alpha-glucosidase mutant and application thereof in synthesis of alpha-arbutin, and the alpha-glucosidase mutant comprises the following steps: maltose and hydroquinone are taken as substrates, the recombinant bacteria are taken as a catalyst, catalytic reaction is carried out under a heating condition, and the alpha-arbutin is obtained. According to the synthesis method, maltose and hydroquinone are used as reaction substrates, and alpha-arbutin is generated through whole-cell catalysis; meanwhile, the sequence of the alpha-glucosidase mutant is integrated onto a pRSEDuet-1 expression vector and transferred into escherichia coli BL21 (DE3) for expression, a reaction system of recombinant bacteria is optimized, the optimal catalytic condition is determined, the yield of alpha-arbutin under the optimal condition is 24.8 g / L, the yield can reach 95.6% and is improved by 1.2 times compared with that of an original strain, and the alpha-glucosidase mutant has a good application prospect.
Owner:云合(天津)生物技术有限公司

Method for separating and purifying gamma-aminobutyric acid from whole cell or enzymatic conversion liquid

The invention discloses a method for separating and purifying gamma-aminobutyric acid from whole cells or enzymatic conversion liquid. The method comprises the following steps: removing thalli and large-particle impurities, denaturating, decolorizing and removing impurities, crystallizing for the first time, washing for the first time, crystallizing for the second time, washing for the second time and drying. According to the present invention, the thermal denaturation of the protein, the active carbon decoloration and the flocculation impurity removal are integrated, such that the solid-liquid separation frequency is reduced, the problems of difficult filtration and easy leakage of the powdered active carbon are solved, and the purity and the yield of the gamma-aminobutyric acid are significantly improved. In the whole separation and purification process, the pH value is not adjusted, the cost is saved, impurities are reduced, and the ion removal process is omitted. And collecting the primary crystallization mother liquor and washing liquor for secondary crystallization, so that the yield of the final product is greatly improved. According to the separation and purification method, the purity of the obtained gamma-aminobutyric acid is greater than 99%, the yield is greater than 92%, and the crystal light transmittance is greater than 99%. The method provided by the invention is simple, efficient and low in cost, and has a wide application prospect.
Owner:天津慧健生物科技有限公司 +1

Recombinant escherichia coli for producing nicotinamide ribokinase as well as construction method and application of recombinant escherichia coli

The invention discloses recombinant escherichia coli for producing nicotinamide ribokinase as well as a construction method and application of the recombinant escherichia coli, and belongs to the technical field of biology. The invention constructs nicotinamide ribokinase, and the amino acid sequence of the nicotinamide ribokinase is as shown in SEQ ID NO.7. According to the invention, a recombinant escherichia coli NMN-HS01 for expressing the nicotinamide ribokinase is constructed by utilizing a genetic engineering technology, and the nicotinamide ribokinase expressed by the recombinant bacteria or whole cells of the recombinant bacteria are used for carrying out catalytic reaction, so that efficient production of beta-nicotinamide mononucleotide can be realized. The invention also provides a method for producing beta-nicotinamide mononucleotide, the catalytic reaction is carried out at normal temperature and normal pressure, and the method is environment-friendly; toxic and harmful organic solvents are not used, so that environmental pollution is reduced; the whole catalytic process is a one-step reaction, has the advantages of high conversion rate, simple purification step and simple process, can better save the production cost, and has wide application prospects.
Owner:HEFEI UNIV OF TECH

Method for synthesizing D-psicose by utilizing whole-cell transformed biomass hydrolysate

The invention provides a method for synthesizing D-psicose by using whole-cell transformed biomass hydrolysate, which comprises the following steps: by using a wet cell obtained from a culture solution obtained by inducing and culturing recombinant escherichia coli as a biocatalyst, directly using the biomass hydrolysate as a substrate in the presence of metal ions, and synthesizing D-psicose by using the whole-cell transformed biomass hydrolysate. A catalytic reaction is directly carried out without treatment to prepare D-psicose; the recombinant escherichia coli is the recombinant escherichia coli capable of simultaneously expressing glucose isomerase and D-psicose-3 epimerase. According to the method, the biomass hydrolysate can be converted into the high-concentration D-psicose solution in one step, whole cells are adopted as a catalyst, enzyme purification is not needed, the process steps are reduced, the inhibition effect of impurities in the hydrolysate on the enzyme is reduced, the production cost can be obviously reduced, industrial production is facilitated, and the method is suitable for industrial production. And the conversion rate of the D-psicose can reach more than 15%.
Owner:ZHEJIANG UNIV OF TECH +1

Recombinant strain for expressing phenolic acid decarboxylase as well as construction method and application of recombinant strain

The invention relates to the technical field of gene engineering and recombinase catalysis engineering, in particular to a recombinant strain for expressing phenolic acid decarboxylase as well as a construction method and application of the recombinant strain. According to the invention, a recombinant strain for expressing the phenolic acid decarboxylase PADCs is constructed by heterologous expression of a coding gene PADCs of the phenolic acid decarboxylase. The enzyme liquid of the recombinant strain for expressing the phenolic acid decarboxylase has remarkable catalytic performance, p-coumaric acid can be used as a substrate, the recombinant strain is used for inducing expression, the purified enzyme liquid is used for catalyzing decarboxylation reaction of p-coumaric acid, and p-hydroxystyrene is synthesized; meanwhile, the phenolic acid decarboxylase PADCs has a wide substrate spectrum, the 4-vinylphenol compound can be used as a substrate, bicarbonate is used as a carboxyl source, the freeze-dried whole cell of the recombinant strain is utilized to catalyze the 4-vinylphenol compound to carry out regioselective beta-carboxylation reaction, a series of phenolic acids with biological activity are synthesized by an enzymic method, and meanwhile CO2 is immobilized; and a huge application potential is provided for the utilization of CO2.
Owner:NANJING TECH UNIV

Schizochytrium limacinum powder for reducing methane emission of dairy cow and preparation method thereof

The invention relates to the technical field of feeds, and particularly discloses schizochytrium limacinum powder capable of reducing methane emission of dairy cows, a preparation method of the schizochytrium limacinum powder, and double-layer microalgae whole-cell schizochytrium limacinum powder obtained by the method or microalgae whole-cell schizochytrium limacinum powder with a core schizochytrium limacinum and outer double-layer coating structure. Methanogens in the rumen can utilize hydrogen to reduce carbon dioxide into CH4, according to the feed formula, a multi-layer core-coated structure is adopted, lysozyme is added in the outermost cladding layer of schizochytrium limacinum particles, and 4-hydroxy-3-methoxybenzoic acid, D-alloisoleucine and D-2-aminobutyric acid are added in the middle cladding layer to inhibit the growth of brevibacterium methane and methanomicrobe, so that the growth of the schizochytrium limacinum particles is inhibited, and the yield of the schizochytrium limacinum particles is increased. The Schizochytrium limacinum can regulate the flora structure, promote the metabolism of the flora in the rumen to move towards the propionic acid path, reduce the amount of acetic acid and the B / C ratio, promote digestion and increase the VFA fermentation yield and the propionic acid amount, so that under the condition that the flora fermentation effect is not affected, the methane emission is reduced, the absorption of various nutritional ingredients of the Schizochytrium limacinum is improved, and the content of nutrient substances such as DHA in milk can be remarkably increased after long-term use of the Schizochytrium limacinum can be remarkably increased.
Owner:XIAMEN HUISON BIOTECH CO LTD

L-threonine aldolase mutant R318L / H128N / N90Q and application thereof

The invention relates to L-threonine aldolase, in particular to an L-threonine aldolase mutant R318L / H128N / N90Q and application of the L-threonine aldolase mutant R318L / H128N / N90Q. The amino acid sequence of the L-threonine aldolase mutant is shown as SEQ ID NO: 3, and the L-threonine aldolase mutant is obtained by changing the 318th amino acid of L-threonine aldolase of which the amino acid sequence is SEQ ID NO: 1 into Leu from Arg, changing the 128th amino acid into Asn from His and changing the 90th amino acid into Gln from Asn. The mutant has high catalytic activity in a reaction of catalyzing benzaldehyde and derivatives thereof and glycine to synthesize beta-hydroxyl-alpha-amino acid, when a whole cell expressing R318L / H128N / N90Q is used for catalysis, the diastereoselectivity (de) of benzaldehyde and glycine to synthesize benzene serine is 65.8%, and the yield is 67.7%; the diastereoselectivity (de) of p-fluorobenzene serine synthesized from p-fluorobenzaldehyde and glycine is 77.5%, and the yield of p-fluorobenzene serine is 80.3%. The mutant has application potential in biosynthesis of beta-hydroxyl-alpha-amino acid.
Owner:CHONGQING UNIV

System for producing valerolactam through whole-cell catalysis and application of system

The invention relates to the technical field of bioengineering, in particular to a system for producing valerolactam through whole-cell catalysis and application of the system. The system provided by the invention comprises L-lysine, and also comprises halomonas with the functions of synthesizing 5-aminovaleric acid, inhibiting GabT protein and enhancing beta-alanine coenzyme A transferase. According to the method, L-lysine is taken as a substrate, halomonas is utilized, 5-aminovaleric acid is synthesized firstly, degradation of the 5-aminovaleric acid is reduced by inhibiting the function of GabT protein in the halomonas, the function of beta-alanine coenzyme A transferase is enhanced, the metabolic flux from the 5-aminovaleric acid to the valerolactam is increased, and finally the valerolactam is efficiently produced.
Owner:BEIJING PHABUILDER BIOTECHNOLOGY CO LTD

Power semiconductor device with deep energy level acceptor impurity p base region and manufacturing method

The invention discloses a power semiconductor chip with a deep-energy-level acceptor impurity p base region and a manufacturing method, and belongs to the field of power semiconductor preparation. According to the power semiconductor device chip, deep energy level acceptor impurities are adopted in a p base region to form a p + base region covered by a whole cell, or additional deep energy level acceptor impurities are added on the basis of traditional p + base region doping to form the p + + base region covered by the whole cell; wherein the distance between the energy level position of the deep-energy-level acceptor impurity in silicon and the valence band top EV is more than 0.1 eV. Compared with a traditional power semiconductor device structure, the current turn-off capability of the IGCT device can be effectively improved, and the conduction voltage drop is obviously reduced compared with a traditional structure; the contradiction between the p + base region doping concentration of the IGCT and the current turn-off capability and the conduction voltage drop of the device can be improved.
Owner:北京怀柔实验室 +1

Plasmid, alpha-ketoglutaric acid engineering strain and construction method and application thereof

The invention provides a plasmid, an alpha-ketoglutaric acid engineering strain and a construction method and application of the alpha-ketoglutaric acid engineering strain, the strain is obtained by adopting a directional transformation method, transcriptional levels of katE, katG, sodB and grxA genes are up-regulated, a catR gene and a katA gene are heterologously expressed, a high-copy plasmid pETKG is carried, and the plasmid simultaneously expresses L-glutamate oxidase LGOX genes from Streptomyces sp and Chain A; the strain self-synthesized catalase eliminates H2O2 generated in the process of producing alpha-ketoglutaric acid through enzyme catalysis, engineering bacteria of L-glutamate oxidase LGOX expressed by pETKG plasmids are used for performing whole-cell catalysis on L-sodium glutamate to synthesize alpha-ketoglutaric acid, and the engineering strain is a high-level engineering strain capable of industrially and stably producing alpha-ketoglutaric acid.
Owner:TIANJIN UNIV OF SCI & TECH

Method for producing nicotinamide mononucleotide through double-enzyme'one-pot method 'catalysis

The invention discloses a method for producing nicotinamide mononucleotide through double-enzyme'one-pot process' catalysis. According to the method, under the optimal conditions that EBY-NRK with the concentration of 25 mg / mL, EBY-PPK with the concentration of 10 mg / mL, NR with the concentration of 5 mM, ATP with the concentration of 1.5 mM, a phosphoric acid donor with the concentration of 15 mM and a Mg < 2 + >-containing substance with the concentration of 2 mM can be catalytically generated into 82.8% of NMN at the temperature of 30 DEG C and the pH value of 6.5, the ATP cost is reduced by 75%, and after a whole-cell enzyme preparation is repeatedly used for five times, the enzyme activity is still larger than 50%. The invention further develops a whole-cell catalyst displayed on the surface of the recombinant yeast, the problem of conversion inhibition caused by accumulation feedback of by-products in the NMN biosynthesis process is solved by coupling an ATP regeneration system, and the cost is effectively reduced while a good NMN product generation rate is obtained.
Owner:SOUTH CHINA UNIV OF TECH +1

Preparation method of inositol

PendingCN121380217AHydrolasesTransferasesPhosphateInositol monophosphatase
The invention provides an application of inositol monophosphate in an enzyme catalysis reaction system for preparing inositol. The invention also provides a preparation method of the inositol, the starch is used as a substrate, glucan phosphorylase, glucose phosphate mutase, inositol-3-phosphate synthase and inositol monophosphate are added as enzyme catalysts to catalyze the substrate to generate the inositol, the inositol monophosphate is derived from Archaeoglobus fulgidus, the amino acid sequence is shown as SEQ ID NO: 12, or the amino acid sequence is shown as SEQ ID NO: 1, or the amino acid sequence is shown as SEQ ID NO: 2, or the amino acid sequence is shown as SEQ ID NO: 3, or the amino acid sequence is shown as SEQ ID NO: 4, or the amino acid sequence is shown as SEQ ID NO: 5, or the amino acid sequence is shown as SEQ ID NO: 6. The inositol monophosphate is derived from Thermococcus kodakarensis, and the amino acid sequence of the inositol monophosphate is as shown in SEQ ID NO: 13; or the inositol monophosphate is derived from Pseudothermotoga lettinae, and the amino acid sequence of the inositol monophosphate is as shown in SEQ ID NO: 14. Inositol-3-phosphate synthetase and inositol monophosphate with good performance are screened, high-concentration starch is efficiently catalyzed to be converted into inositol by a one-pot method in a whole-cell feeding mode, and NAD < + > and other coenzymes do not need to be used. Under a 60L reaction system, 200g / L of corn starch is catalyzed, the unit yield of the prepared inositol reaches 161g / L, and the method has a good industrial application prospect.
Owner:SICHUAN AIHE ZHIXING BIOTECHNOLOGY CO LTD

An Immunogenic Composition of Disease-Associated Antigens for Use in a Vaccine, Antibody Production and Immunodiagnostic Tests

The invention is based on the deletion of 21 amino acids from the C-terminal region of the S2 subunit of SARS-CoV2-S protein and transporting the Si subunit, which is fused to S2 to the cell membranes. In this way, the presentation of the antigenic S1 subunit of SARS-CoV2-S protein in large amounts and in its natural structure in the cell membrane and its use as a whole cell or cell membrane has been determined as a new vaccination protocol for the SARS-CoV-2. Designing the S2 subunit of SARS-CoV2-S protein as a carrier, fusing any bacterial, viral, and tumor proteins with antigenic properties and transporting it to the cell membrane will be a comprehensive vaccination protocol that will cover all bacteria, viruses and even tumors.
Owner:SAHIN FIKRET

Fusion P450 enzyme mutant, method for improving VD3 catalytic activity and method for generating 25 (OH) VD3 by whole cells

The invention relates to the technical field of agricultural biology, in particular to a fusion P450 enzyme mutant, a method for improving VD3 catalytic activity and a method for generating 25 (OH) VD3 through whole cells. The invention constructs a fusion P450 enzyme VK1-CYP116B46-L21 and a self-sufficiency fusion P450 enzyme mutant with improved activity, wherein the self-sufficiency fusion P450 enzyme mutant is used for catalyzing vitamin D3 to synthesize calcifediol; vD3 is taken as a substrate, glucose, a cosolvent and a wet thallus induced by recombinant escherichia coli for simultaneously expressing fusion P450 enzyme and glucose dehydrogenase are added, and the highest yield of 25 (OH) VD3 within 24 hours after catalytic reaction can reach 3.26 g / L; whole cells are directly used as a catalyst, enzyme purification is not needed, glucose dehydrogenase is introduced, and glucose is used as a substrate to regenerate a cofactor NAD (P) H, so that addition of expensive cofactors is avoided, the production cost is reduced, and industrial production is facilitated.
Owner:INSTITUTE OF ANIMAL SCIENCES OF CHINESE ACADEMY OF AGRICULTURAL SCIENCES